A Phase III Study of BD0801 Combined With Chemotherapy in Recurrent, Platinum-resistant Epithelial Ovarian Cancer
Jiangsu Simcere Pharmaceutical Co., Ltd.
Jiangsu Simcere Pharmaceutical Co., Ltd.
Mayo Clinic
ARCAGY/ GINECO GROUP
Pfizer
Holy Name Medical Center, Inc.
Ruhr University of Bochum
Ruhr University of Bochum
Novartis
National Cancer Institute (NCI)
Swiss Cancer Institute
GOG Foundation
Mayo Clinic
AGC Biologics S.p.A.
AGC Biologics S.p.A.
National Cancer Institute (NCI)
GlaxoSmithKline
Leiden University Medical Center
Janssen Research & Development, LLC
New Mexico Cancer Research Alliance
European Organisation for Research and Treatment of Cancer - EORTC
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
European Organisation for Research and Treatment of Cancer - EORTC
Swiss Cancer Institute
Janssen Pharmaceutical K.K.